GHO Capital-backed ELIQUENT Life Sciences completed the acquisition of the consulting business of Azzur Group for $56m.

GHO Capital-backed ELIQUENT Life Sciences, an international provider of quality compliance and regulatory affairs consulting services to biotech, pharma and medtech companies, completed the acquisition of the consulting business of Azzur Group, a service provider to FDA-regulated pharmaceutical and biotech companies, for $56m. With this acquisition, ELIQUENT gains deeper technical delivery capabilities that support life sciences companies across the product development lifecycle. Azzur Consulting’s network of seasoned quality, validation, and engineering professionals enable a deep domain of expertise and add to ELIQUENT’s GxP compliance, equipment and process validation, facility qualification, and IT system validation.